Methylprednisolone and Radiculopathy - a phase IV clinical study of FDA data

Summary:

Radiculopathy is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Radiculopathy when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Radiculopathy?

Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly) is found to be associated with 740 drugs and 608 conditions by eHealthMe. Check the latest studies of Radiculopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 72 people (0.12%) have Radiculopathy.

Could Methylprednisolone cause Radiculopathy?

Among these 72 people:

How long have people been on Methylprednisolone when they have Radiculopathy? *

What is the gender of people who have Radiculopathy when taking Methylprednisolone? *

female: 79.17 %
male: 20.83 %

What is the age of people who have Radiculopathy when taking Methylprednisolone? *

What are other drugs people take besides Methylprednisolone? *

What are other side effects people have besides Radiculopathy? *

Pain: 48 people, 66.67%
Hypoaesthesia (reduced sense of touch or sensation): 42 people, 58.33%
Spinal Osteoarthritis (joint cartilage loss in spine): 42 people, 58.33%
Bone Disorder: 41 people, 56.94%
Fever: 40 people, 55.56%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 39 people, 54.17%
Fatigue (feeling of tiredness): 38 people, 52.78%
Stress And Anxiety: 38 people, 52.78%
Injury: 37 people, 51.39%
Back Pain: 37 people, 51.39%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 24 people, 33.33%
Sleep Apnea Syndrome: 22 people, 30.56%
Bone Cancer Metastatic: 12 people, 16.67%
Bone Density Decreased: 12 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 16.67%
Breast Cancer: 12 people, 16.67%
High Blood Pressure: 9 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 11.11%
Pain: 8 people, 11.11%
Insomnia (sleeplessness): 6 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and have Radiculopathy?

- Check whether Radiculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:

Methylprednisolone (59,645 reports)

Radiculopathy treatments and more:

Radiculopathy (5,655 reports)

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Radiculopathy:

Radiculopathy (740 drugs)

Browse all the conditions that are associated with Radiculopathy:

Radiculopathy (608 conditions)

Related publications that referenced our studies

Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.